154 related articles for article (PubMed ID: 18288118)
1. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
Wen SW; Yang T; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Walker MC
J Perinatol; 2008 May; 28(5):324-9. PubMed ID: 18288118
[TBL] [Abstract][Full Text] [Related]
2. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
[TBL] [Abstract][Full Text] [Related]
3. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.
Yang J; Xie RH; Krewski D; Wang YJ; Walker M; Wen SW
Int J Infect Dis; 2011 May; 15(5):e336-41. PubMed ID: 21345707
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy.
Yang T; Walker MC; Krewski D; Yang Q; Garner P; Fraser W; Olatunbosun O; Nimrod C; Wen SW
Acta Obstet Gynecol Scand; 2007; 86(11):1310-6. PubMed ID: 17963058
[TBL] [Abstract][Full Text] [Related]
5. Prescription drug use in pregnancy.
Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
[TBL] [Abstract][Full Text] [Related]
6. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
[TBL] [Abstract][Full Text] [Related]
7. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
8. National patterns of medication use during pregnancy.
Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
[TBL] [Abstract][Full Text] [Related]
9. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
Brent RL
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
[TBL] [Abstract][Full Text] [Related]
10. Use of prescription medications with a potential for fetal harm among pregnant women.
Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
[TBL] [Abstract][Full Text] [Related]
11. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
Viktil KK; Engeland A; Furu K
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
[TBL] [Abstract][Full Text] [Related]
12. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
[TBL] [Abstract][Full Text] [Related]
13. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.
Schirm E; Meijer WM; Tobi H; de Jong-van den Berg LT
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):182-8. PubMed ID: 15140513
[TBL] [Abstract][Full Text] [Related]
14. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
[TBL] [Abstract][Full Text] [Related]
15. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.
Kebede B; Gedif T; Getachew A
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):462-8. PubMed ID: 19334033
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy.
Gidai J; Acs N; Bánhidy F; Czeizel AE
Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181
[TBL] [Abstract][Full Text] [Related]
17. Prescription of medications during pregnancy: accidents, compromises, and uncertainties.
Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):613-7. PubMed ID: 16941520
[No Abstract] [Full Text] [Related]
18. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
Bertsche T; Haas M; Oberwittler H; Haefeli WE; Walter-Sack I
Dtsch Med Wochenschr; 2006 May; 131(18):1016-22. PubMed ID: 16673226
[TBL] [Abstract][Full Text] [Related]
19. FDA boxed warnings: how to prescribe drugs safely.
O'Connor NR
Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
